Detalles de la búsqueda
1.
Willingness to use a drug consumption room among people who use drugs in Lyon, France, a city with no open scene of drug use (the TRABOUL survey).
Harm Reduct J
; 20(1): 149, 2023 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37845698
2.
Screening and care for alcohol use disorder in France: expectations, barriers and levers using a mixed-methods approach.
BMC Public Health
; 20(1): 358, 2020 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32188436
3.
The use of a thromboelastometry-based algorithm reduces the need for blood product transfusion during orthotopic liver transplantation: A randomised controlled study.
Eur J Anaesthesiol
; 36(11): 825-833, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31567574
4.
Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C.
Liver Int
; 37(8): 1122-1127, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28423231
5.
Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin.
Ther Drug Monit
; 38(6): 684-692, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27559840
6.
Care of hepatitis C virus infection in France: modifications in three consecutive surveys between 1995 and 2010.
Liver Int
; 34(9): 1349-57, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25368876
7.
Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients.
BMC Infect Dis
; 14: 150, 2014 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24650094
8.
End-ischemic hypothermic oxygenated perfusion for extended criteria donors in liver transplantation: a multicenter, randomized controlled trial-HOPExt.
Trials
; 24(1): 379, 2023 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37280696
9.
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis.
J Hepatol
; 54(5): 1011-9, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21145828
10.
Association of anti-E1E2 antibodies with spontaneous recovery or sustained viral response to therapy in patients infected with hepatitis C virus.
Hepatology
; 52(5): 1531-42, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20890942
11.
Impact on the Gut Microbiota of Intensive and Prolonged Antimicrobial Therapy in Patients With Bone and Joint Infection.
Front Med (Lausanne)
; 8: 586875, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33748154
12.
Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus.
World J Hepatol
; 12(12): 1326-1340, 2020 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33442458
13.
Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure.
Liver Int
; 29(3): 420-6, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18795900
14.
Prediction of sustained virological response by ribavirin plasma concentration at week 4 of therapy in hepatitis C virus genotype 1 patients.
Antivir Ther
; 13(4): 607-11, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18672540
15.
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy.
Clin Res Hepatol Gastroenterol
; 42(4): 313-318, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29551607
16.
Correction: End-ischemic hypothermic oxygenated perfusion for extended criteria donors in liver transplantation: a multicenter, randomized controlled trial-HOPExt.
Trials
; 24(1): 530, 2023 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37580803
17.
Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT).
Clin Res Hepatol Gastroenterol
; 41(1): 56-65, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27554134
18.
Sofosbuvir plus daclatasvir with or without ribavirin for chronic hepatitis C infection: Impact of drug concentration on viral load decay.
Dig Liver Dis
; 48(11): 1351-1356, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27498075
19.
Anti-E1E2 antibodies do predict response to triple therapy in treatment-experienced Hepatitis C Virus-cirrhosis cases.
Clin Res Hepatol Gastroenterol
; 39(6): 699-704, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25900002
20.
Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy.
Hepat Mon
; 15(9): e28879, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26500683